The VEP and PERG have been proven and accepted as a viable clinical tool in the assessment of diseases of the retina ganglion cells. The Diopsys® Neuro Optic Vision Assessment Vision (NOVA) Testing System generates a battery of retinal responses evoked by viewing horizontal/checkerboard grating patterns with optimized contrast levels and visual field sizes.